Ending the ‘Pill Penalty’ Costly for CMS and Medicare Beneficiaries, Say Harvard Researchers – RamaOnHealthcare

Ending the ‘Pill Penalty’ Costly for CMS and Medicare Beneficiaries, Say Harvard Researchers

Giving small-molecule drugs the same 13-year exemption from price negotiation as biologics would cost the federal government billions of dollars, argue three Harvard researchers

Ending the ‘Pill Penalty’ Costly for CMS and Medicare Beneficiaries, Say Harvard Researchers – RamaOnHealthcare

Giving small-molecule drugs the same 13-year exemption from price negotiation as biologics would cost the federal government billions of dollars, argue three Harvard researchersThe Inflation Reduction Act (IRA) exempts biologics from CMS price negotiation for 13 years and small molecules for nine. The pharmaceutical industry has been pushing for a change that would give small [...]